Kezar Life Sciences, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -1.06%129.830.0%$1302.62m
OCGNOcugen, Inc. -15.58%8.830.0%$1058.59m
NVAXNovavax, Inc. -12.15%161.3092.9%$633.58m
AMGNAmgen, Inc. -0.88%221.971.3%$544.13m
VRTXVertex Pharmaceuticals, Inc. -0.30%207.811.9%$517.30m
REGNRegeneron Pharmaceuticals, Inc. -0.45%444.702.7%$500.90m
GILDGilead Sciences, Inc. 1.71%63.821.0%$488.25m
ILMNIllumina, Inc. -3.56%401.573.5%$459.50m
ALXNAlexion Pharmaceuticals, Inc. -0.16%147.962.0%$341.00m
BIIBBiogen, Inc. -0.96%264.051.7%$317.36m
CRSPCRISPR Therapeutics AG -4.57%113.640.6%$270.01m
BNGOBionano Genomics, Inc. -18.25%6.990.0%$247.21m
EXASEXACT Sciences Corp. -5.79%119.2418.4%$222.37m
SGENSeagen Inc. -1.70%145.425.8%$205.47m
PACBPacific Biosciences of California, Inc. -7.77%28.567.2%$151.10m

Company Profile

Kezar Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco, California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.